Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Neoplasms 1Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1Gastrointestinal Neoplasms 1

Interventions

Specimen Handling 482pembrolizumab 456Magnetic Resonance Spectroscopy 419Carboplatin 322Cyclophosphamide 317Biopsy 270Cisplatin 263Radiotherapy 238Paclitaxel 227Gemcitabine 222Bevacizumab 214Nivolumab 190fludarabine 185venetoclax 172Drug Therapy 165Blood Specimen Collection 157Dexamethasone 156Oxaliplatin 154Injections 152Capecitabine 152Fluorouracil 144Docetaxel 142Standard of Care 138Radiosurgery 136Rituximab 125Pemetrexed 115durvalumab 113atezolizumab 110Leucovorin 110Surveys and Questionnaires 104

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Glutamyl Aminopeptidase × 1 year × Clear all
NCT05649943 2025-09-03

APPROACH

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase NA Recruiting
566 enrolled
Genitourinary

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

NCT05441163 2025-06-24

ProActIF-01

Institut Curie

Phase NA Recruiting
50 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡